Recruiting
Acute leukaemia
RecruitingA study of enzomenib in adult patients with relapsed or refractory acute leukemia, including those with MLL rearrangement or NPM1 mutation.
InvestigationalNo placebo
A study of enzomenib in adult patients with relapsed or refractory acute leukemia, including those with MLL rearrangement or NPM1 mutation.
InvestigationalNo placebo
- Disease:Acute leukaemia
- Substances:Enzomenib
Countries:
Belgium
Belgium- Participants:0–17 years · 18–64 years · 65+ years
- Substances:Enzomenib



